RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @shinji_toki: #アピキサバン が透析患者にはいいようだが。さあ、よく読まないと。 https://t.co/3VzALSflOt
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
#アピキサバン が透析患者にはいいようだが。さあ、よく読まないと。
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @DrDerekConnolly: In this meta-analysis OACs did not reduce the risk of stroke in AF on dialysis. Warfarin, dabigatran, & rivaroxaban…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @DrDerekConnolly: In this meta-analysis OACs did not reduce the risk of stroke in AF on dialysis. Warfarin, dabigatran, & rivaroxaban…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
RT @JACCJournals: In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with sig…
In patients with #AFib on dialysis, oral anticoagulatants, warfarin, dabigatran, and rivaroxaban were associated with significantly higher bleeding risk compared to apixaban. https://t.co/uUpAF3sF9J #JACC #cvCoag https://t.co/ZwQfKpH9TM
In this meta-analysis OACs did not reduce the risk of stroke in AF on dialysis. Warfarin, dabigatran, & rivaroxaban had more bleeding than apixaban/ no anticoagulant. https://t.co/DZLUZqJanU
RT @Office_j: 【長期透析AF嶺へのOACは有効?/ JACC】 観察研究16報 [71877例] メタ解析:長期透析歴のあるAF例では、VKA、DOACともに、脳卒中・塞栓症の有意抑制作用は観察されず。 https://t.co/ZWdNGiZCvb
RT @Office_j: 【長期透析AF嶺へのOACは有効?/ JACC】 観察研究16報 [71877例] メタ解析:長期透析歴のあるAF例では、VKA、DOACともに、脳卒中・塞栓症の有意抑制作用は観察されず。 https://t.co/ZWdNGiZCvb
RT @Yuki_Sahashi: 心房細動を有する透析患者の抗凝固薬のメタ解析 from JACC. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis |…
RT @Yuki_Sahashi: 心房細動を有する透析患者の抗凝固薬のメタ解析 from JACC. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis |…
工野先生、おめでとうございます!
RT @Yuki_Sahashi: 心房細動を有する透析患者の抗凝固薬のメタ解析 from JACC. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis |…
RT @Office_j: 【長期透析AF嶺へのOACは有効?/ JACC】 観察研究16報 [71877例] メタ解析:長期透析歴のあるAF例では、VKA、DOACともに、脳卒中・塞栓症の有意抑制作用は観察されず。 https://t.co/ZWdNGiZCvb
【長期透析AF嶺へのOACは有効?/ JACC】 観察研究16報 [71877例] メタ解析:長期透析歴のあるAF例では、VKA、DOACともに、脳卒中・塞栓症の有意抑制作用は観察されず。 https://t.co/ZWdNGiZCvb
https://t.co/XYBtElsexW JACC in press today! This article provides the debate regarding dialysis patients with atrial fibrillation and anticoagulation.